19-35030595-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_001037.5(SCN1B):c.-226C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00723 in 152,202 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0074 ( 15 hom., cov: 31)
Exomes 𝑓: 0.0014 ( 0 hom. )
Consequence
SCN1B
NM_001037.5 5_prime_UTR
NM_001037.5 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0370
Genes affected
SCN1B (HGNC:10586): (sodium voltage-gated channel beta subunit 1) Voltage-gated sodium channels are heteromeric proteins that function in the generation and propagation of action potentials in muscle and neuronal cells. They are composed of one alpha and two beta subunits, where the alpha subunit provides channel activity and the beta-1 subunit modulates the kinetics of channel inactivation. This gene encodes a sodium channel beta-1 subunit. Mutations in this gene result in generalized epilepsy with febrile seizures plus, Brugada syndrome 5, and defects in cardiac conduction. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 19-35030595-C-T is Benign according to our data. Variant chr19-35030595-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 675777.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00743 (1093/147180) while in subpopulation AFR AF= 0.0234 (959/41000). AF 95% confidence interval is 0.0222. There are 15 homozygotes in gnomad4. There are 508 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1093 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SCN1B | NM_001037.5 | c.-226C>T | 5_prime_UTR_variant | 1/6 | ENST00000262631.11 | ||
SCN1B | NM_199037.5 | c.-226C>T | 5_prime_UTR_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SCN1B | ENST00000262631.11 | c.-226C>T | 5_prime_UTR_variant | 1/6 | 1 | NM_001037.5 | P1 | ||
SCN1B | ENST00000415950.5 | c.-226C>T | 5_prime_UTR_variant | 1/3 | 1 | ||||
SCN1B | ENST00000638536.1 | upstream_gene_variant | 1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00740 AC: 1089AN: 147074Hom.: 15 Cov.: 31
GnomAD3 genomes
AF:
AC:
1089
AN:
147074
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00139 AC: 7AN: 5022Hom.: 0 Cov.: 0 AF XY: 0.000717 AC XY: 2AN XY: 2788
GnomAD4 exome
AF:
AC:
7
AN:
5022
Hom.:
Cov.:
0
AF XY:
AC XY:
2
AN XY:
2788
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00743 AC: 1093AN: 147180Hom.: 15 Cov.: 31 AF XY: 0.00709 AC XY: 508AN XY: 71694
GnomAD4 genome
AF:
AC:
1093
AN:
147180
Hom.:
Cov.:
31
AF XY:
AC XY:
508
AN XY:
71694
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 14, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at